We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases BsUFA III Commitment Letter, Promising Faster Reviews
FDA Releases BsUFA III Commitment Letter, Promising Faster Reviews
The FDA will create six supplement categories for biologics license applications (BLAs) based on submission content, with review goals of between three and 10 months.